Summary
ICRWorld's Chronic Kidney Disease (CKD) Drugs market research report provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.
The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players.
Global Chronic Kidney Disease (CKD) Drugs Market; Product Segment Analysis
Hyperphosphatemia; Dietary phosphate binders and dietary phosphate restriction
Hypocalcemia; Calcium supplements and possibly calcitriol
Hyperparathyroidism; Calcitriol or vitamin D analogues
Anemia; Iron replacement therapy and erythropoiesis-stimulating agents
Global Chronic Kidney Disease (CKD) Drugs Market; Application Segment Analysis
Hospital use
Clinic use
Household
Global Chronic Kidney Disease (CKD) Drugs Market; Regional Segment Analysis
USA
Europe
Japan
China
India
South East Asia
The Players mentioned in our report
Johnson & Johnson
Abbott Laboratories
F. Hoffmann-La Roche
Takeda Pharmaceuticals
Actavis
Akebia Therapeutic
Raptor Pharmaceuticals
Rockwell Medical
AMAG Pharmaceuticals
Sanofi
Reata Pharmaceuticals
Cara Therapeutics
FibroGen